Related Experiment Video
Updated: Aug 5, 2026

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
Published on: May 11, 2015
Navigating the Complexities of Pulmonary Hypertension Care: Unique Challenges in PAH Management
Karla Cruz Morel1, Namita Sood2, Roberto Bernardo3
1Prisma Health Heart and Vascular Institute University of South Carolina Columbia South Carolina USA.
Despite advances, diagnosing and treating pulmonary hypertension (PH) remains challenging due to patient and system barriers. This review examines these obstacles and proposes solutions for better pulmonary arterial hypertension (PAH) care in the US.
Area of Science:
- Cardiology
- Pulmonology
- Health Services Research
Background:
- Pulmonary hypertension (PH) is a complex group of disorders with elevated pulmonary artery pressure.
- Despite improved awareness, screening, therapies, and guidelines, diagnosis and treatment delays persist.
- Pulmonary arterial hypertension (PAH) is a specific subtype facing significant care challenges.
Purpose of the Study:
- To examine the persistent barriers to timely diagnosis and treatment of PH in the United States.
- To identify both patient-related and system-level obstacles impacting PH care.
- To propose actionable recommendations for improving PH management and treatment.
Main Methods:
- Review of current literature and clinical practice guidelines related to PH diagnosis and treatment.
- Analysis of patient-related factors influencing PH care access and adherence.
- Examination of system-level factors, including healthcare infrastructure and referral patterns.
Main Results:
- Significant barriers exist in patient recognition of symptoms and adherence to treatment.
- Systemic issues include diagnostic delays, fragmented care, and inadequate access to specialized centers.
- Pulmonary arterial hypertension (PAH) care is particularly affected by these multifaceted challenges.
Conclusions:
- Addressing patient-related and system-level barriers is crucial for improving PH outcomes.
- Integrating a comprehensive framework can bridge existing gaps in PH care delivery.
- Actionable recommendations are provided to enhance the diagnosis, management, and treatment of PH in the US.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation